Skip to content

Author

Na-Na Peng

We have 3 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Adverse childhood experiences and chronic liver diseases: Dose-response, type-specific associations, and mediation analyses.

BACKGROUND Adverse childhood experiences (ACEs) are linked to long-term health risks, yet their association with chronic liver diseases (CLDs) and mediating roles of mental health, lifestyles, and socioeconomic status remain undefined. We aimed to investigate these associations. METHODS This prospective cohort study...

Ying Li, Shi-Yu Wang, Na-Na Peng et al. · 0 citations
Open access Aug 2026

Machine learning quantifies immuno-virological interactions: a TRIPOD+AI compliant prediction model for HIV-1 salvage therapy outcomes

The developed XGBoost model overcomes the limitations of traditional linear scoring and achieves precise prediction of HIV salvage therapy outcomes by quantifying immune modulatory effects and therapeutic exhaustion markers.

De-Fu Yuan, Yang-Yang Liu, Shan-Shan Liu et al. · 0 citations
Review Open access Jul 2026

Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment.

This narrative review examines the transition from task-specific discrimination AI to large language models (LLMs), multimodal foundation models, and agentic AI, and outlines the future directions for safe AI model deployment based on multimodal foundation models, prospective and federated evaluation, lifecycle governa...

Na-Na Peng, Mary Yue Wang, S. J. Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.